Shariah compliance overview
Not HalalClimb Bio, Inc. (CLYM) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Climb Bio, Inc.
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody.
Climb Bio, Inc. (CLYM) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.
- Business Activity
- 100.00%Limit 5%Fail
- Interest-bearing debt
- 0.09%Limit 30%Pass
- Interest-bearing securities and assets
- 36.00%Limit 30%Fail
- Dividend purification
- 100.00%Share of dividends to give to charityPurification calculator
Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Climb Bio, Inc. (CLYM). Current Akinda screening label: Not Halal.
